GLP-1R Antagonist 1 Based on 7 publication(s) in Google Scholar GLP-1R Antagonist 1 (compound 5d) is an orally active, CNS penetrant and non-competitive antagonist of glucagon-like peptide 1 receptor (GLP-1R) , with an IC 50 of 650 nM
This dual-action approach enhances weight loss by promoting a feeling of fullness and slowing gastric emptying, making it easier to manage caloric intake
*Product contains benzyl alcohol as an inactive ingredient Contraindications for Benzyl Alcohol This preparation is not advised in patients who are sensitive to cobalt and/or vitamin B12
Case Report: A male patient in his mid-60s with Crohns disease experienced chronic flares despite conventional medications and Hyperbaric Oxygen Therapy
and Cluster-4 with fatigue (94%), PEM (94%), dizziness (94%), brain fog (94%), GI (88%), and palpitations (86%) 129
We utilize comprehensive laboratory testing protocols that exceed industry standards while providing evidence-based treatment plans tailored to individual needs